Nordea Investment Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-94,439
Closed -$3.9M 930
2024
Q2
$3.9M Sell
94,439
-15,397
-14% -$611K ﹤0.01% 578
2024
Q1
$4.7M Buy
109,836
+30,066
+38% +$1.17M 0.01% 552
2023
Q4
$3.14M Sell
79,770
-2,726
-3% -$90.8K ﹤0.01% 634
2023
Q3
$2.56M Buy
82,496
+13,673
+20% +$472K ﹤0.01% 649
2023
Q2
$2.26M Sell
68,823
-29,771
-30% -$1.02M ﹤0.01% 672
2023
Q1
$3.56M Sell
98,594
-142
-0.1% -$4.97K 0.01% 587
2022
Q4
$2.88M Hold
98,736
﹤0.01% 611
2022
Q3
$3.91M Buy
98,736
+14,859
+18% +$680K 0.01% 578
2022
Q2
$3.22M Sell
83,877
-12,156
-13% -$462K ﹤0.01% 631
2022
Q1
$4.8M Buy
+96,033
New +$4.95M 0.01% 593

Other funds holding ASTH

Nordea Investment Management's ASTH Position: Q3 2024 in Review

Nordea Investment Management sold out of Astrana Health (ASTH) in Q3 2024, closing a stake of 94,439 shares — an estimated $3.9M sold.

Nordea Investment Management first reported a position in ASTH in Q1 2022 and held it in 10 quarters. The position peaked at $4.8M in Q1 2022. 189 funds tracked by Wall St. Rank hold ASTH as of Q3 2024.

  • Nordea Investment Management reported no remaining Astrana Health position as of Q3 2024 after selling out during the quarter.
  • Nordea Investment Management sold 94,439 Astrana Health shares in Q3 2024, an estimated $3.9M.
  • Nordea Investment Management first reported a position in Astrana Health in Q1 2022 and held it in 10 quarters.
  • Nordea Investment Management's Astrana Health position peaked at $4.8M in Q1 2022.
  • 189 funds tracked by Wall St. Rank held Astrana Health as of Q3 2024.

Based on Nordea Investment Management's 13F filing for Q3 2024, filed 5 Nov 2024.